Biogen Idec to present new drug data at ECTRIMS 2013 Zenopa ... including information on both approved and investigational products. The firm will share the latest clinical findings on established therapies such as Tysabri, Tecfidera and Fampyra, as well as newer agents including Plegridy, Anti-Lingo-1 and ... |
